Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFCAP.L Regulatory News (FCAP)

  • There is currently no data for FCAP

AGM Trading Statement

21 Sep 2020 07:00

RNS Number : 5059Z
finnCap Group PLC
21 September 2020
 

Date: 21 September 2020

finnCap Group PLC

AGM Trading Statement

finnCap Group PLC ("finnCap" or the "Company") provides the following update on current trading in advance of its Annual General Meeting ("AGM") to be held later today.

With our preliminary results in July, we reported record Q1 results, a strong pipeline for Q2 and a substantial increase in the group's cash resources. Q2's pipeline has been executed with a significant contribution from the equity capital markets team, where significant corporate fundraising continued. 

As a result, we expect to report Group revenue for the six months ending 30 September 2020 of not less than £19.5m, up c.37 per cent. on last year (H120: £14.2m). Given the level of operational gearing in the business there will be a significant uplift in profitability on the prior period. Costs have remained under control and our cash position has further improved. At the close of business on 18 September 2020, net cash was £12.4m(1).

Although trading for the last few months has been exceptionally strong, we remain mindful of the overall social and economic backdrop to the current operating environment. However, our pipeline for Q3 2021 is good and this gives us confidence that we will deliver a satisfactory result for the full year.

As the result of our trading performance and strengthened balance sheet, we expect to return to dividend payments with our interim results which are expected to be released in November.

Sam Smith, CEO said:

"Although the external environment has been dominated by COVID-19 and its economic and social impact, our second quarter has been strong, with continued equity issuances by clients to support COVID-19 related activities, to support balance sheets and to raise funds to develop strong business cases including one of the only IPOs to take place during lock down. The M&A market is quiet but the team still closed a number of transactions and continued to win new mandates for H2.

In September we started working from our new office at One Bartholomew Close bringing together the finnCap and Cavendish teams in a single location. This required significant capital investment however, our performance in H1 means that our cash resources are higher now than in June.

We are in a good position to help our clients meet and respond to the economic challenges of the months ahead."

(1) Cash at 18 September excludes £0.9m due to HMRC under COVID-19 arrangements repayable over the next 6-9 months.

Contacts:

finnCap Group PLC Tel: +44 (0) 207 220 0500

Sam Smith, Chief Executive Officer

Richard Snow, Chief Financial Officer

Grant Thornton (Nominated Adviser) Tel: +44 (0) 20 7383 5100

Philip Secrett/Samantha Harrison/Seamus Fricker

finnCap Limited (Broker) Tel: +44 (0) 20 7220 0500

Rhys Williams

Sapience Communications (PR adviser to the Group) Tel: +44 (0) 20 3195 3240

Richard Morgan Evans

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMPPUCWBUPUGBU
Date   Source Headline
19th Oct 20227:15 amRNSRule 2.9 Announcement
18th Oct 20222:58 pmEQSForm 8.3 - Maitland Institutional Services Limited: Re finnCap plc
18th Oct 20227:00 amRNSResponse to offer speculation
3rd Oct 20227:00 amRNSTotal Voting Rights
28th Sep 20227:00 amRNSDirectorate Change
15th Sep 202211:16 amRNSResult of AGM
15th Sep 20227:00 amRNSAGM Trading Update
1st Sep 20227:00 amRNSCEO Transition Completed
1st Sep 20227:00 amRNSTotal Voting Rights
5th Aug 20227:00 amRNSDividend Declaration, Annual Report & AGM Notice
1st Aug 20227:00 amRNSTotal Voting Rights
14th Jul 20227:00 amRNSResults for year ended 31 March 2022
8th Jul 20227:00 amRNSAppointment of Executive Directors
1st Jul 20227:00 amRNSTotal Voting Rights
21st Jun 20227:00 amRNSProposed New CEO and appointment of new Directors
1st Jun 20227:00 amRNSBlock Admission Return and Total Voting Rights
16th May 20227:00 amRNSDirectorate Change
29th Apr 20227:00 amRNSTotal Voting Rights
28th Apr 20227:00 amRNSBuilding a leading advisory business
14th Apr 20227:23 amRNSFY22 Unaudited Revenue
1st Apr 20227:00 amRNSTotal Voting Rights
10th Mar 20227:00 amRNSTrading Update
1st Mar 20227:00 amRNSTotal Voting Rights
8th Feb 20229:18 amRNSDirector Dealing
1st Feb 20227:00 amRNSTotal Voting Rights
28th Jan 202210:22 amRNSHolding(s) in Company
28th Jan 202210:21 amRNSHolding(s) in Company
26th Jan 20227:00 amRNSOption Exercise, Dealing Amendment and TVR
25th Jan 20227:00 amRNSAppointment of Non-Executive Director
31st Dec 20217:00 amRNSTotal Voting Rights
9th Dec 20215:25 pmRNSHolding(s) in Company
8th Dec 20214:04 pmRNSCOVID Option Exercises and EBT Holdings in Company
1st Dec 20217:00 amRNSBlock Admission Return and Total Voting Rights
18th Nov 20217:00 amRNSInterim Results and Dividend
2nd Nov 20217:00 amRNSNotice of Interims and Investor Presentation
1st Nov 20217:00 amRNSTotal Voting Rights
19th Oct 202111:01 amRNSHolding(s) in Company
4th Oct 20217:00 amRNSH1 22 Unaudited Revenues – strong growth on H1 21
1st Oct 20217:00 amRNSTotal Voting Rights
24th Sep 20217:00 amRNSExercise of Options and Total Voting Rights
23rd Sep 202111:21 amRNSResult of AGM
23rd Sep 20217:00 amRNSAGM Trading Statement
15th Sep 20219:51 amRNSAGM Update
1st Sep 20217:00 amRNSTotal Voting Rights
30th Jul 20217:00 amRNSTotal Voting Rights
22nd Jul 20217:00 amRNSSecond Interim Dividend
7th Jul 202110:00 amRNSAnnual Report and Annual General Meeting Notice
6th Jul 20217:00 amRNSDirector Dealing, Option Exercise and TVR
1st Jul 20217:00 amRNSPreliminary results - year ended 31 March 2021
1st Jul 20217:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.